- Kane Biotech press release (OTCQB:KNBIF): Q2 total revenue was C$27,997 compared to C$620,437 in the three months ended June 30, 2024.
- Net loss was C$(348,541) compared to a net loss of C$(1,215,996) for the quarter ended June 30, 2024.
Kane Biotech reports Q2 results

Related
New Fortress Energy reports larger losses in Q2
3 hours ago
0
secures $132.6M U.S. Navy contract modification
6 hours ago
1
Boeing secures $343.99M U.S. Army contract modification
6 hours ago
1
Graphjet receives Nasdaq letter
6 hours ago
1
Trending
Popular
Suchi Reddy and a study in belonging
1 week ago
3
© FBT Company 2025. All rights are reserved